| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Revenue | $114.7M | — |
| R&D Expense | $138.5M | +2.4% |
| SG&A Expense | $36.1M | -6.0% |
| Operating Income | -$59.9M | +67.4% |
| Pre-tax Income | -$55.6M | +69.1% |
| Income Tax | $893K | — |
| Net Income | -$56.5M | +68.6% |
| EPS (Basic) | -$0.25 | +78.8% |
| EPS (Diluted) | -$0.25 |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $46.1M | +43.5% |
| Short-term Investments | $248.4M | -6.0% |
| Accounts Receivable | $5.3M | — |
| Current Assets | $309.9M | +1.1% |
| Total Assets | $315.3M | +1.1% |
| Current Liabilities | $45.0M | -12.8% |
| Long-term Debt | $0 | -100.0% |
| Line Item | 2024-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.5M | +97.8% |
| Capital Expenditures | $0 | — |
| Investing Cash Flow | $29.0M | +126.2% |
| Financing Cash Flow | -$11.5M | -106.0% |
| Free Cash Flow | -$3.5M | +97.8% |
| +78.8% |
| Total Liabilities |
| $285.8M |
| +14.7% |
| Stockholders' Equity | $29.5M | -53.0% |